European Heart Journal Cardiovascular Pharmacotherapy Impact Factor, Indexing, Ranking

European Heart Journal Cardiovascular Pharmacotherapy (EHJCP) is a scholarly journal dedicated to publishing research in the field of Medicine. Oxford University Press is the publisher of this esteemed journal. The P-ISSN assigned to European Heart Journal Cardiovascular Pharmacotherapy is 2055-6837 and its abbreviated form is Eur Heart J Cardiovasc Pharmacother.

The European Heart Journal - Cardiovascular Pharmacotherapy (EHJ-CVP) is an international, English language, peer-reviewed journal with a specific focus on clinical cardiovascular pharmacology. It publishes original articles concerning clinical research, with new and established drugs and methods, as well as meta-analysis and topical reviews. The journal aims to improve the pharmacological treatment of patients with cardiovascular disease through interpreting and integrating new scientific developments within this area. While the focus is on clinical topics, basic research articles from fields such as physiology and molecular biology which contribute to an understanding of cardiovascular drug therapy are also considered, such as articles relevant to new drug development and evaluation, physiological and pharmacological bases of drug action, metabolism, drug interactions and side effects.

Abbreviation : ISO Journal abbreviation refers to the shortened form or acronym used to represent the full title of a scholarly journal. The ISO4 Abbreviation of European Heart Journal Cardiovascular Pharmacotherapy Journal is Eur Heart J Cardiovasc Pharmacother.

The Ranking of the Journal in 2024 is 1824. Ranking systems aim to provide an indication of a journal's quality, influence, and prestige within a specific field or discipline.

The Journal's Impact Factor in 2024 is 7.1. it is all calculated by Clarivate, which means how many times a particular citation has been published in the past two years.

List of All Journal Impact Factors

The Journal SCImago in 2024 is 1.641. It is measured by the number of citations which are made by the particular journals, and the journal from where the citations arrived from.

The Journal's H-Index in 2024 is 35. The H-index is calculated on how many times a particular author is cited and the number of published papers that a particular author has.

The Journal's Quartile is Q1. A quartile has three points, which are the upper quartile, median, and lower quartile. The main motive of the quartile is to calculate the interquartile range, that resembles the changes across the median.

The Journal is indexed in (Indexing details)

• 1. Web of Science
• 2. UGC
• 3. Scopus
• 4. PubMed
• 5. Medline
• 6. Google Scholar

Indexing services aim to make it easier for researchers, scholars, and readers to discover and access articles from various journals within a specific field or discipline.

The Editor-in-chief of the Journal is Professor Stefan Agewall

Processing/Submission Fee : Article submission/Processing fees (APC), also known as manuscript Publication fees or processing fees (APC), are charged by journals to authors for submitting/publishing their research papers/article.

The APC/Submission (Publication) Fee of the Journal is 3828.72 EUR

Call for paper : The Journal invites original research contributions for consideration of publication in European Heart Journal Cardiovascular Pharmacotherapy journal.

Journal seeking submissions in the broad areas of Medicine that align with journal's focus on Medicine.

for details about call for paper please visit to the official website of the journal to check the details about call for papers.

Publishing in European Heart Journal Cardiovascular Pharmacotherapy involves the following steps:

• Research: Conduct high-quality, impactful research in the field of Medicine.
• Familiarize Yourself: Read and understand the aims and scope of European Heart Journal Cardiovascular Pharmacotherapy to ensure your work aligns with their focus.
• Manuscript Preparation: Prepare your manuscript according to the European Heart Journal Cardiovascular Pharmacotherapy guidelines, including formatting, length, and referencing style.
• Submission: Submit your manuscript through the journal's online submission system.

• Journal Website
• PubMed
• Scopus
• SCImago